Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PayPal Holdings Inc (Symbol: PYPL), where a total of 112,649 contracts have traded so far, representing approximately 11.3 million underlying shares. That amounts to about 97.3% of PYPL's average daily trading volume over the past month of 11.6 million shares. Particularly high volume was seen for the $250 strike put option expiring January 20, 2023, with 4,805 contracts trading so far today, representing approximately 480,500 underlying shares of PYPL. Below is a chart showing PYPL's trailing twelve month trading history, with the $250 strike highlighted in orange:
Clarus Corp (Symbol: CLAR) options are showing a volume of 44,101 contracts thus far today. That number of contracts represents approximately 4.4 million underlying shares, working out to a sizeable 97.1% of CLAR's average daily trading volume over the past month, of 4.5 million shares. Especially high volume was seen for the $40 strike call option expiring December 16, 2022, with 7,777 contracts trading so far today, representing approximately 777,700 underlying shares of CLAR. Below is a chart showing CLAR's trailing twelve month trading history, with the $40 strike highlighted in orange:
And Cytokinetics Inc (Symbol: CYTK) options are showing a volume of 9,479 contracts thus far today. That number of contracts represents approximately 947,900 underlying shares, working out to a sizeable 87.3% of CYTK's average daily trading volume over the past month, of 1.1 million shares. Particularly high volume was seen for the $65 strike call option expiring November 18, 2022, with 4,648 contracts trading so far today, representing approximately 464,800 underlying shares of CYTK. Below is a chart showing CYTK's trailing twelve month trading history, with the $65 strike highlighted in orange:
For the various different available expirations for PYPL options, CLAR options, or CYTK options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
